EAM Investors’s Medifast MED Stock Holding History

EAM Investors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,528	Closed	-$1.85M	–	348
2021 Q2	$1.85M	Sell	6,528 -1,103	-14%	-$299K	0.29%	149
2021 Q1	$1.62M	Sell	7,631 -2,149	-22%	-$514K	0.24%	194
2020 Q4	$1.92M	Buy	+9,780	New	+$1.73M	0.31%	130
2018 Q4	–	Sell	-9,909	Closed	-$2.19M	–	295
2018 Q3	$2.19M	Sell	9,909 -9,820	-50%	-$1.99M	0.33%	147
2018 Q2	$3.16M	Sell	19,729 -21,044	-52%	-$2.69M	0.5%	79
2018 Q1	$3.81M	Sell	40,773 -10,945	-21%	-$818K	0.63%	30
2017 Q4	$3.61M	Buy	51,718 +5,384	+12%	+$357K	0.65%	24
2017 Q3	$2.75M	Buy	+46,334	New	+$2.31M	0.37%	86
2017 Q1	–	Sell	-23,867	Closed	-$994K	–	347
2016 Q4	$994K	Buy	+23,867	New	+$961K	0.13%	259
2014 Q3	–	Sell	-37,724	Closed	-$1.15M	–	343
2014 Q2	$1.15M	Buy	+37,724	New	+$1.18M	0.22%	260

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

EAM Investors's MED Position: Q3 2021 in Review

EAM Investors sold out of Medifast (MED) in Q3 2021, closing a stake of 6,528 shares — an estimated $1.85M sold.

EAM Investors first reported a position in MED in Q2 2014 and held it in 10 quarters. The position peaked at $3.81M in Q1 2018. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

EAM Investors reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
EAM Investors sold 6,528 Medifast shares in Q3 2021, an estimated $1.85M.
EAM Investors first reported a position in Medifast in Q2 2014 and held it in 10 quarters.
EAM Investors's Medifast position peaked at $3.81M in Q1 2018.
296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.